Laboratory diagnosis of infection with West Nile virus in serum specimens
Detection of antibodies to West Nile virus (WNV) in serum can be used to support the diagnosis of recent WNV infection.
该测试应仅用于诊断目的。
Test Id | Reporting Name | Available Separately | 总是执行 |
---|---|---|---|
WNGS | West Nile Virus Ab, IgG, S | 不 | Yes |
WNMS | West Nile Virus Ab, IgM, S | 不 | Yes |
WNVSI | 西尼罗河血清解释 | 不 | Yes |
Enzyme-Linked Immunosorbent Assay (ELISA)
Arbovirus
Flavivirus
蚊子出现脑炎
病毒脑炎
西尼罗河病毒(WNV)
Serum
收集容器/管:
Preferred:Serum gel
可接受:Red top
标本卷:0.5 mL
If not ordering electronically, complete, print, and send aMicrobiology Test Request(T244)带试样。
0.4毫升
Gross hemolysis | Reject |
脂肪血症 | Reject |
大黄色 | Reject |
热灭活标本 | Reject |
标本类型 | 温度 | Time | Special Container |
---|---|---|---|
Serum | 冷藏(首选) | 14 days | |
冷冻 | 14 days |
Laboratory diagnosis of infection with West Nile virus in serum specimens
西尼罗河病毒(WNV)是一种蚊子传播的黄病毒(单链RNA),主要感染鸟类,但也可以感染人类和马匹。WNV于1937年首次与乌干达西尼罗河地区的受感染者隔离。直到1999年在纽约市的鸟类中识别出病毒感染之前,WNV才在东半球发现,在非洲,亚洲,中东和欧洲的分布广泛。(1-3)在2012年,总共有。5674例WNV病例已报告给疾病控制与预防中心(CDC),其中2873(51%)被归类为神经侵染疾病(例如,脑膜炎或脑膜炎),286例(5%)(5%)导致死亡。(2)
Most people who are infected with WNV will not develop clinical signs of illness. It is estimated that about 20% of those who become infected will develop West Nile fever with mild symptoms, including fever, headache, myalgia, and occasionally a skin rash on the trunk of the body. Case fatality rates among patients hospitalized during recent outbreaks have ranged from 4% to 14%. Advanced age is the most important risk factor for death, and patients older than 70 years of age are at particularly high risk.(1)
通过证明特定的IgG和血清标本中的IgM类抗体,可以最好地实现实验室诊断。聚合酶链反应(PCR)测试(WNVP / West Nile病毒(WNV),分子检测,PCR,血浆)可以在特定抗体时检测来自最近WNV感染患者(即感染后3至5天)血浆中的血浆标本中的WNV RNA病毒尚未存在。然而,由于已知WNV感染的患者,检测的可能性相对较低,因为PCR检测的敏感性约为55%,血液的敏感性约为55%,血液的敏感性约为55%。
IgG:负
IGM:负
参考值适用于所有年龄段
血清中西尼罗河病毒(WNV)的IgG级抗体的存在表明过去的某个时候感染了WNV。感染后3周,几乎所有受感染的人都应开发对WNV的IgG抗体。如果怀疑怀疑急性期感染,应在感染后大约7天内与大约14至21天感染的标本进行比较,以证明2个血清样本之间的IgG抗体水平上升。
Presence of specific IgM-class antibodies in a serum specimen is consistent with acute-phase infection with WNV. By the 8th day of illness, most infected persons will have detectable serum IgM antibody to WNV; in most cases it will be detectable for at least 1 to 2 months following disease resolution and in some cases will be detectable for 12 months or longer.
The absence of IgM antibodies to WNV is consistent with lack of acute-phase infection with this virus. Specimens collected too early in the acute phase (eg, before 8 to 10 days postinfection) may be negative for IgM-specific antibodies to WNV. If WNV is suspected, a second specimen collected approximately 14 days postinfection should be tested.
In the very early stages of WNV infection, IgM may be detectable in cerebrospinal fluid (CSF) before it becomes detectable in serum.
Test results should be used in conjunction with a clinical evaluation and other available diagnostic procedures.
阴性测试结果在免疫抑制患者中的重要性尚不确定。
在过去几个月内接受输血或其他血液产品的人可能无效。
False-negative results due to competition by high levels of IgG, while theoretically possible, have not been observed.
False-positive results may occur in persons vaccinated for flaviviruses (eg, yellow fever, Japanese encephalitis, dengue)
False-positive results may occur in patients infected with other arboviruses, including flaviviruses (eg, dengue virus) and alphavirusis (eg, LaCrosse [California] Encephalitis virus, Eastern or Western equine encephalitis virus, St. Louis virus) and in persons previously infected with West Nile virus (WNV).
Because closely related arboviruses exhibit serologic cross-reactivity, it sometimes may be epidemiologically important to attempt to pinpoint the infecting virus by conducting cross-neutralization tests using an appropriate battery of closely related viruses.
WNV antibody results for cerebrospinal fluid (CSF) should be interpreted with caution. Complicating factors include low antibody levels found in CSF, passive transfer of antibody from blood, and contamination via a traumatic lumbar puncture.
1. Petersen LR, Marafin AA: West Nile Virus: a primer for the clinician. Ann Intern Med. 2002;137:173-179
2. Centers for Disease Control and Prevention (CDC): West Nile virus and other arboviral diseases-United States, 2012. MMWR Morb Mortal Wkly Rep. 2013;62(25):513-517
3. Brinton MA: The molecular biology of West Nile Virus: a new invader of the western hemisphere. Ann Rev Microbiol. 2002;56:371-402
4. Centers for Disease Control and Prevention (CDC): Provisional surveillance summary of the West Nile virus epidemic. United States, January-November 2002. MMWR Morb Mortal Wkly Rep. 2002;51(50):1129-1133
5.疾病控制与预防中心(CDC):输血接受者中西尼罗河病毒感染的研究。MMWR Morb Mortal WklyRep。2002; 51(43):973-974
IgG:
Polystyrene microwells are coated with recombinant West Nile virus (WNV) antigen. Diluted serum specimens and controls are incubated in the wells to allow specific antibody present in the specimens to react with the antigen. Nonspecific reactants are removed by washing, and peroxidase-conjugated antihuman IgG is added and reacts with specific IgG. Excess conjugate is removed by washing. Enzyme substrate and chromogen are added, and the color is allowed to develop. After adding the stop reagent, the resultant color change is quantified by a spectrophotometric reading of optical density (OD). Specimen OD readings are compared with reference cutoff readings to determine results.(Package insert: Flavivirus [West Nile] ELISA IgG. Focus Technologies;10/16/2012)
IGM:
Polystyrene microwells are coated with the antihuman antibody specific for IgM (u-chain). Diluted serum specimens and controls are incubated in the wells, and IgM present in the specimen binds to the antihuman antibody (IgM specific) in the wells. Nonspecific reactants are removed by washing. WNV antigen is then added to the wells and incubated. If anti-WNV IgM is present in the specimen, the WNV antigen binds to the anti-WNV in the well. Unbound WNV antigen is then removed by washing the well. Mouse antiflavivirus conjugated with horseradish peroxidase (HRP) is then added to the wells and incubated. If WNV antigen has been retained in the well by the antiflavivirus in the specimen, the mouse antiflavivirus:HRP binds to WNV antigen in the wells. Excess conjugate is removed by washing. Enzyme substrate and chromogen are added, and the color is allowed to develop. After adding the Stop reagent, the resultant color change is quantified by a spectrophotometric reading of OD that is directly proportional to the amount of antigen-specific IgM present in the specimen. Specimen OD readings are compared with reference cutoff OD readings to determine results.(Package insert: Flavivirus [West Nile] IgM Capture ELISA. Focus Technologies; 06/01/2015)
星期一,星期三,星期五
This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.
IgG-86789
IGM-86788